Uruguay’s Ministry of Public Health (MSP) has approved Mounjaro, a drug initially developed for diabetes treatment, for use in addressing obesity. The medication, containing tirzepatide, has gained significant attention due to its effectiveness in promoting weight loss. However, authorities emphasize that Mounjaro is not a “magic bullet” solution. The drug works by mimicking a natural hormone, aiding in blood sugar control and appetite suppression. Approval signifies a new tool in combating Uruguay’s rising obesity rates, but it will likely be prescribed alongside lifestyle changes. While promising, the MSP stresses the importance of realistic expectations and a comprehensive approach to weight management.